SPL 3.16% 9.2¢ starpharma holdings limited

Ann: VIRALEZE distribution in Saudi Arabia - supplementary info, page-39

  1. 9,168 Posts.
    lightbulb Created with Sketch. 796
    I find the partners , distributers that they have "outsourced" these marketing responsibilities extremely lacking and I only hope they have learnt teh contractual lessons so they can either get those product moving by bringing skills inhouse or enforcing existing contracts or canning existing contracts and reissing with suitable controls so the product gets out there. All assuming it is a good product. Have shareholders wrongly assumed it's effectiveness or market size- i don't think so?

    Answer- beats the crap out of me why they seem to have followed same pathway when it didn't work 1st time? Marketing to womens health is not cheap but it is sticky as one generation and the girl telegraph quickly sorts out good and bad products regarding health along with so many specilaist womens health Dr's. Non of this seems to have been leveraged off in any country??? why why why?

    What are management doing to proactively correct the situation of stuff all sales revenue back to SPL ?
    Last edited by Teddyward: 07/02/22
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
-0.003(3.16%)
Mkt cap ! $37.90M
Open High Low Value Volume
9.5¢ 9.9¢ 9.0¢ $44.25K 465.7K

Buyers (Bids)

No. Vol. Price($)
1 3999 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 630 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.